[Uveitis treated with biotherapy and/or DMARD: Analysis from the French Pharmacovigilance Study Base].
Sign Up to like & getrecommendations! Published in 2018 at "Journal francais d'ophtalmologie"
DOI: 10.1016/j.jfo.2017.11.012
Abstract: PURPOSE To report the characteristics of uveitis cases occurring while on biologic therapy or disease-modifying antirheumatic drugs (DMARDs) reported to the French national pharmacovigilance database. METHODS All the uveitis cases occurring in patients with chronic… read more here.
Keywords: dmard; uveitis treated; biologic therapy; pharmacovigilance ... See more keywords
POS0142 MINIMAL DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS AND ASSOCIATED FACTORS: REAL LIFE DATA FROM A SINGLE CENTER
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.714
Abstract: Psoriatic arthritis (PsA) is a heterogeneous disease and GRAPPA have proposed Minimal disease activity (MDA) as a composite outcome measure and has been validated in PsA.In this study, we aimed to evaluate the characteristics, MDA… read more here.
Keywords: line dmard; disease activity; disease; dmard ... See more keywords
Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms21186847
Abstract: CD4+T-lymphocytes are relevant in the pathogenesis of rheumatoid arthritis (RA), however, their potential involvement in early RA remains elusive. Methotrexate (MTX) is a commonly used disease-modifying antirheumatic drug (DMARD), but its mechanism has not been… read more here.
Keywords: cd4; dmard; cytokine expression; rheumatoid arthritis ... See more keywords